Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Treatment Options in Cardiovascular Medicine|March 8, 2008
Repairing damaged myocardium: evaluating cells used for cardiac regenerationAdam J T Schuldt, Michael R Rosen, Glenn R Gaudette, et al.
Annual Review of Pharmacology and Toxicology|October 10, 2017
Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and ProblemsTarek Magdy, Adam J T Schuldt, Joseph C Wu, et al.
Experimental Hematology|October 31, 2003
Donor cell expansion is delayed following nonablative in utero transplantation to treat murine mucopolysaccharidosis type VIIJane E Barker, Adam J T Schuldt, Mark L Lessard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
Successful allogeneic neonatal bone marrow transplantation devoid of myeloablation requires costimulatory blockadeBrian W Soper, Mark D Lessard, Craig D Jude, et al.
Journal of Cardiac Failure|December 16, 2004
Aldosterone directly stimulates cardiac myocyte hypertrophyMarina P Okoshi, Xinhua Yan, Katashi Okoshi, et al.
Communications Biology|October 11, 2018
Doxorubicin induces caspase-mediated proteolysis of KV7.1Anne Strigli, Christian Raab, Sabine Hessler, et al.
Blood Cells, Molecules & Diseases|February 6, 2004
Transplanted ER-MP12hi20-58med/hi myeloid progenitors produce resident macrophages from marrow that are therapeutic for lysosomal storage diseaseBrian W Soper, Ted M Duffy, Mark D Lessard, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 19, 2003
Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic miceXinhua Yan, Robert L Price, Masaharu Nakayama, et al.
Circulation|June 8, 2017
Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac FibrosisPanagiotis Flevaris, Sadiya S Khan, Mesut Eren, et al.
Pageof 2